logo
Select company
Select metric
$ -89.4MEarning Before Interest & Taxes (EBIT)
VS
Market
11
Sector
23
Industry
32
History
60
$ 7.41Close
$ 5.8 - $ 16.39 52-Week Range
Ticker Information

Ticker

DAWN

Company Name

DAY ONE BIOPHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

DAY ONE BIOPHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

DAWN - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -89.4M
3/31/2025$ -61.94M
12/31/2024$ -88.35M
9/30/2024$ -83.62M
6/30/2024$ -165.93M
3/31/2024$ -208.94M
12/31/2023$ -188.92M
9/30/2023$ -177.18M
6/30/2023$ -170.72M
3/31/2023$ -161.57M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • DAY ONE BIOPHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -43.81M.
  • Over the past 5 years, DAY ONE BIOPHARMACEUTICALS INC's average EBIT has been $ -123.52M.
  • The median EBIT for DAY ONE BIOPHARMACEUTICALS INC during this period was $ -115.89M
  • DAY ONE BIOPHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ -43.81M.
  • The lowest EBIT recorded by DAY ONE BIOPHARMACEUTICALS INC in the same timeframe $ -208.94M

DAY ONE BIOPHARMACEUTICALS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
STOK : STOKE THERAPEUTICS INC $ 40.57MAKBA : AKEBIA THERAPEUTICS INC $ -8.34MDNA : GINKGO BIOWORKS HOLDINGS INC $ -316MGERN : GERON CORP $ -59.54MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -160.05MKROS : KEROS THERAPEUTICS INC $ 26.89MNAGE : NIAGEN BIOSCIENCE INC $ 18.33MPHAT : PHATHOM PHARMACEUTICALS INC $ -257.49MANAB : ANAPTYSBIO INC $ -132.52MXNCR : XENCOR INC $ -134.76M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

DAWN - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -208.94M

Minimum

Mar 31, 2024

$ -43.81M

Maximum

Dec 31, 2020

$ -123.52M

Average

$ -115.89M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.48M with a standard deviation of $ 130.46M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.48M
median$ 847.86K
std$ 130.46M